ID   GM06991
AC   CVCL_R580
AS   CVCL_G423
SY   CEPH-1341-NA06991; 1341-8314
DR   CLO; CLO_0036555
DR   cancercelllines; CVCL_R580
DR   Coriell; GM06991
DR   dbMHC; 48583
DR   GEO; GSM25353
DR   GEO; GSM25355
DR   GEO; GSM112393
DR   GEO; GSM112760
DR   GEO; GSM188775
DR   GEO; GSM291587
DR   GEO; GSM316432
DR   GEO; GSM316433
DR   GEO; GSM316434
DR   GEO; GSM420469
DR   GEO; GSM420470
DR   GEO; GSM648858
DR   GEO; GSM861984
DR   GEO; GSM861985
DR   GEO; GSM861986
DR   GEO; GSM861987
DR   GEO; GSM861988
DR   GEO; GSM861989
DR   IGSR; NA06991
DR   IHW; IHW01053
DR   IPD-IMGT/HLA; 25851
DR   Progenetix; CVCL_R580
DR   Wikidata; Q54842432
RX   CelloPub=CLPUB00447;
RX   PubMed=17122850;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24924344;
RX   PubMed=26621101;
WW   https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134102.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,03:01; B*07:02,07:02:01; C*07:02,07:02; DPA1*01:03,01:04; DPB1*04:01,15:01; DQA1*01:02,03:01; DQB1*03:02:01,06:02; DRB1*04:04,15:01; DRB4*01 (IPD-IMGT/HLA=25851).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: CNV analysis.
CC   Omics: Genome sequenced.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 22
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   PubMed=17122850; DOI=10.1038/nature05329;
RA   Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D.,
RA   Fiegler H., Shapero M.H., Carson A.R., Chen W.-W., Cho E.K., Dallaire S.,
RA   Freeman J.L., Gonzalez J.R., Gratacos M., Huang J., Kalaitzopoulos D.,
RA   Komura D., MacDonald J.R., Marshall C.R., Mei R., Montgomery L.,
RA   Nishimura K., Okamura K., Shen F., Somerville M.J., Tchinda J.,
RA   Valsesia A., Woodwark C., Yang F.-T., Zhang J.-J., Zerjal T., Zhang J.,
RA   Armengol L., Conrad D.F., Estivill X., Tyler-Smith C., Carter N.P.,
RA   Aburatani H., Lee C., Jones K.W., Scherer S.W., Hurles M.E.;
RT   "Global variation in copy number in the human genome.";
RL   Nature 444:444-454(2006).
//
RX   PubMed=20856902; DOI=10.1371/journal.pbio.1000480;
RA   Cheung V.G., Nayak R.R., Wang I.X.-R., Elwyn S., Cousins S.M., Morley M.,
RA   Spielman R.S.;
RT   "Polymorphic cis- and trans-regulation of human gene expression.";
RL   PLoS Biol. 8:e1000480.1-e1000480.14(2010).
//
RX   PubMed=21397061; DOI=10.1016/j.ajhg.2011.02.004;
RA   Campbell C.D., Sampas N., Tsalenko A., Sudmant P.H., Kidd J.M.,
RA   Malig M., Vu T.H., Vives L., Tsang P., Bruhn L., Eichler E.E.;
RT   "Population-genetic properties of differentiated human copy-number
RT   polymorphisms.";
RL   Am. J. Hum. Genet. 88:317-332(2011).
//
RX   PubMed=24924344; DOI=10.1186/1756-0500-7-360;
RA   Hariani G.D., Lam E.J., Havener T., Kwok P.-Y., McLeod H.L.,
RA   Wagner M.J., Motsinger-Reif A.A.;
RT   "Application of next generation sequencing to CEPH cell lines to
RT   discover variants associated with FDA approved chemotherapeutics.";
RL   BMC Res. Notes 7:360.1-360.10(2014).
//
RX   PubMed=26621101; DOI=10.1016/j.jmoldx.2015.08.005;
RA   Pratt V.M., Everts R.E., Aggarwal P., Beyer B.N., Broeckel U.,
RA   Epstein-Baak R., Hujsak P., Kornreich R., Liao J., Lorier R.,
RA   Scott S.A., Smith C.-Y.H., Toji L.H., Turner A., Kalman L.V.;
RT   "Characterization of 137 genomic DNA reference materials for 28
RT   pharmacogenetic genes: a GeT-RM collaborative project.";
RL   J. Mol. Diagn. 18:109-123(2016).
//